Logo
Search for

Volume 67, Issue 3, Pages 471-476 (March 2009)


View previous. 7 of 48 View next.

Fluorescence-Guided Bone Resection in Bisphosphonate-Associated Osteonecrosis of the Jaws

Christoph Pautke, MD, DDSCorresponding Author Informationemail address, Florian Bauer, MD, DDS, Thomas Tischer, MD, Kilian Kreutzer, MD, DDS§, Jochen Weitz, MD, DDS, Marco Kesting, MD, DDS, Frank Hölzle, MD, DDS⁎⁎, Andreas Kolk, MD, DDS††, Stephen R. Stürzenbaum, PhD‡‡, Klaus-Dietrich Wolff, MD, DDS§§

Purpose

To date, the therapy of bisphosphonate-associated osteonecrosis of the jaws (BONJ) has been hampered by the lack of imaging modalities that enable the extent of necrosis to be visualized. This study aims to demonstrate the feasibility of tetracycline fluorescence guided bone resection in the surgical management of BONJ.

Patients and Methods

Following a 10-day preoperative administration of doxycycline in patients suffering from BONJ, sufficient doxycycline is incorporated into viable bone to be visualized with a certified medical lamp emitting exciting light at 400 to 460 nm.

Results

Viable and necrotic bone can be discriminated intraoperatively in a routine and reproducible manner by doxycycline bone fluorescence.

Conclusion

In the therapy of BONJ, conservative concepts are to be favored. The fact that necrotic bone can now be selectively resected signifies an improvement of the conservative surgical therapy of BONJ.

 Consultant, Department of Oral and Cranio-Maxillofacial Surgery, Technische Universtität München, Munich, Germany

 Resident, Department of Oral and Cranio-Maxillofacial Surgery, Technische Universtität München, Munich, Germany

 Resident, Department of Orthopedic Surgery, Technische Universtität München, Munich, Germany

§ Resident, Department of Oral and Cranio-Maxillofacial Surgery, Technische Universtität München, Munich, Germany

 Resident, Department of Oral and Cranio-Maxillofacial Surgery, Technische Universtität München, Munich, Germany

 Consultant, Department of Oral and Cranio-Maxillofacial Surgery, Technische Universtität München, Munich, Germany

⁎⁎ Senior Consultant, Department of Oral and Cranio-Maxillofacial Surgery, Technische Universtität München, Munich, Germany

†† Senior Consultant, Department of Oral and Cranio-Maxillofacial Surgery, Technische Universtität München, Munich, Germany

‡‡ Senior Lecturer, Pharmaceutical Science Division, King's College London, London, England

§§ Professor and Head of Department, Department of Oral and Cranio-Maxillofacial Surgery, Technische Universtität München, Munich, Germany

Corresponding Author InformationAddress correspondence and reprint requests to Dr Pautke: Department of Oral and Cranio-Maxillofacial Surgery, Technische Universtität München, Ismaninger Strasse 22, D-81675 Munich, Germany

PII: S0278-2391(08)01595-4

doi:10.1016/j.joms.2008.09.037


View previous. 7 of 48 View next.